Found: 2
Select item for more details and to access through your institution.
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1519, doi. 10.3390/cancers11101519
- By:
- Publication type:
- Article
DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00781-8
- By:
- Publication type:
- Article